ABOUT THE SERVICE
Our proprietary T-MATE platform leverages the acidic environment found in the tumor microenvironment to locally activate T cell engagers (TCEs), minimizing on-target toxicity and enabling the development of safer and more effective therapeutics.
Information is owner-confirmed
Last updated 1 month ago
Price range